Most ALS patients (>95%) have transactive DNA binding protein of ~43 kDa (TDP-43) inclusions in postmortem studies, whereas Tau is not noteworthy [55] (except for Guam ALS/parkinsonism, which is mainly a tauopathy [56]). The gene discussed is MAPT; the disease is tauopathy.